Caseware UK (AP4) 2022.0.179 2022.0.179 2022-12-312022-12-312022-01-0123falseNo description of principal activity0truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 13669806 2021-12-31 13669806 2022-01-01 2022-12-31 13669806 2021-01-01 2021-12-31 13669806 2022-12-31 13669806 c:Director2 2022-01-01 2022-12-31 13669806 d:Buildings d:LongLeaseholdAssets 2022-01-01 2022-12-31 13669806 d:Buildings d:LongLeaseholdAssets 2022-12-31 13669806 d:FurnitureFittings 2022-01-01 2022-12-31 13669806 d:FurnitureFittings 2022-12-31 13669806 d:FurnitureFittings d:OwnedOrFreeholdAssets 2022-01-01 2022-12-31 13669806 d:OwnedOrFreeholdAssets 2022-01-01 2022-12-31 13669806 d:CurrentFinancialInstruments 2022-12-31 13669806 d:CurrentFinancialInstruments d:WithinOneYear 2022-12-31 13669806 d:ShareCapital 2022-12-31 13669806 d:RetainedEarningsAccumulatedLosses 2022-12-31 13669806 c:OrdinaryShareClass1 2022-01-01 2022-12-31 13669806 c:OrdinaryShareClass1 2022-12-31 13669806 c:FRS102 2022-01-01 2022-12-31 13669806 c:AuditExempt-NoAccountantsReport 2022-01-01 2022-12-31 13669806 c:FullAccounts 2022-01-01 2022-12-31 13669806 c:PrivateLimitedCompanyLtd 2022-01-01 2022-12-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 13669806









KENSAL HOUSE NURSERY LTD







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE PERIOD ENDED ENDED 31 DECEMBER 2022

 
KENSAL HOUSE NURSERY LTD
REGISTERED NUMBER: 13669806

STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2022

2022
Note
£

Fixed assets
  

Tangible assets
  
84,189

  
84,189

Current assets
  

Debtors: amounts falling due within one year
 5 
54,938

Cash at bank and in hand
 6 
23,366

  
78,304

Creditors: amounts falling due within one year
 7 
(401,822)

Net current (liabilities)/assets
  
 
 
(323,518)

Total assets less current liabilities
  
(239,329)

  

Net (liabilities)/assets
  
(239,329)


Capital and reserves
  

Called up share capital 
  
1

Profit and loss account
  
(239,330)

  
(239,329)


Page 1

 
KENSAL HOUSE NURSERY LTD
REGISTERED NUMBER: 13669806
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 DECEMBER 2022

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the Period ended in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




O F Rostron
Director

Date: 6 October 2023

The notes on pages 3 to 9 form part of these financial statements.

Page 2

 
KENSAL HOUSE NURSERY LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED ENDED 31 DECEMBER 2022

1.


General information

Kensal House Nursery Limited is a private company limited by shares and incorporated in England. Its registered office is 101 New Cavendish Street, 1st Floor South, London, W1W 6XH.
The principal activity of the company is that of child day-care services.
The financial statements are presented in Sterling, which is the functional currency of the company.
The company was incorporated on 8 October 2021 and began trading on the same day.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

Going concern

The financial statements have been prepared on the going concern basis. The company is dependent on the directors and shareholders for financial support, which the directors are confident will continue for a period of at least another 12 months following the approval of these financial statements.
As at 31 December 2022, the company had net liabilities of £229,869. The directors and shareholders have indicated their present intention to provide adequate finance to enable the company to continue in operational existence, and on this basis the directors considers it appropriate to prepare the financial statements on the going concern basis.
The financial statements do not reflect any adjustments that would result from a withdrawal of inancial support by the directors and shareholders.

Page 3

 
KENSAL HOUSE NURSERY LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED ENDED 31 DECEMBER 2022

2.Accounting policies (continued)

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.4

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of Financial Position. The assets of the plan are held separately from the Company in independently administered funds.

 
2.5

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Page 4

 
KENSAL HOUSE NURSERY LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED ENDED 31 DECEMBER 2022

2.Accounting policies (continued)


2.5
Tangible fixed assets (continued)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on a reducing balance basis.

Depreciation is provided on the following basis:

Long-term leasehold property
-
10%
Fixtures and fittings
-
25%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.6

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.7

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.8

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.9

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

The Company has elected to apply the recognition and measurement provisions of IFRS 9 Financial Instruments (as adopted by the UK Endorsement Board) with the disclosure requirements of Sections 11 and 12 and the other presentation requirements of FRS 102.

Financial instruments are recognised in the Company's Statement of Financial Position when the Company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets
Page 5

 
KENSAL HOUSE NURSERY LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED ENDED 31 DECEMBER 2022

2.Accounting policies (continued)


2.9
Financial instruments (continued)


Basic financial assets, which include trade and other receivables, cash and bank balances, are initially measured at their transaction price including transaction costs and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other receivables due with the operating cycle fall into this category of financial instruments.

Other financial assets

Other financial assets, which includes investments in equity instruments which are not classified as subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the recognised transaction price. Such assets are subsequently measured at fair value with the changes in fair value being recognised in the profit or loss. Where other financial assets are not publicly traded, hence their fair value cannot be measured reliably, they are measured at cost less impairment.

Impairment of financial assets

Financial assets are assessed for indicators of impairment at each reporting date. 

Financial assets are impaired when events, subsequent to their initial recognition, indicate the estimated future cash flows derived from the financial asset(s) have been adversely impacted. The impairment loss will be the difference between the current carrying amount and the present value of the future cash flows at the asset(s) original effective interest rate.

If there is a favourable change in relation to the events surrounding the impairment loss then the impairment can be reviewed for possible reversal. The reversal will not cause the current carrying amount to exceed the original carrying amount had the impairment not been recognised. The impairment reversal is recognised in the profit or loss.

Financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instruments any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other payables, bank loans and other loans are initially measured at their transaction price after transaction costs. When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. Discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade payables are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade payables are classified as current liabilities if the payment is
Page 6

 
KENSAL HOUSE NURSERY LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED ENDED 31 DECEMBER 2022

2.Accounting policies (continued)


2.9
Financial instruments (continued)

due within one year. If not, they represent non-current liabilities. Trade payables are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.


3.


Employees

The average monthly number of employees, including directors, during the Period ended was 23.


4.


Tangible fixed assets





Long-term leasehold property
Fixtures and fittings
Total

£
£
£



Cost or valuation


Additions
17,756
72,266
90,022



At 31 December 2022

17,756
72,266
90,022



Depreciation


Charge for the Period ended on owned assets
746
5,087
5,833



At 31 December 2022

746
5,087
5,833



Net book value



At 31 December 2022
17,010
67,179
84,189

Page 7

 
KENSAL HOUSE NURSERY LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED ENDED 31 DECEMBER 2022

5.


Debtors

2022
£


Trade debtors
51,185

Other debtors
3,753

54,938



6.


Cash and cash equivalents

2022
£

Cash at bank and in hand
23,366

23,366



7.


Creditors: Amounts falling due within one year

2022
£

Trade creditors
25,461

Amounts owed to group undertakings
168,900

Other taxation and social security
51,139

Other creditors
107,124

Accruals and deferred income
49,198

401,822



8.


Share capital

2022
£
Allotted, called up and fully paid


1 Ordinary share of £1.00
1


The company issued 1 Ordinary share of £1.00 at incorporation.

Page 8

 
KENSAL HOUSE NURSERY LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED ENDED 31 DECEMBER 2022

9.


Pension commitments

The company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund. The pension cost charge represents contributions payable by the company to the fund.

 
Page 9